바로가기
메인메뉴로 바로가기
콘텐츠 바로가기
하단메뉴로 바로가기
패밀리사이트 바로가기


소속

  • 산부인과학교실

직위

  • 임상조교수

연구실 위치

전화/팩스

  • /

학력사항

  • 2002 - 2008 연세대학교 의과대학 의학과 학사
    2013 - 2017 연세대학교 의과대학 의학과 박사

교육 및 연구 경력

  • 2008.05 - 2011.05 공중보건의
    2011.05 - 2012.02 연세대학교 세브란스병원 인턴 수료
    2012.03 - 2016.02 연세대학교 세브란스병원 산부인과 전공의 수료
    2016.03 - 2017.02 연세대학교 의과대학 산부인과학교실 임상강사 (부인종양학)
    2017.03 - 2018.02 연세대학교 의과대학 산부인과학교실 임상연구조교수
    2018.03 - 2019.02 Visiting Research Scientist, Medical Oncology, Yale Cancer Center, New Haven, CT, USA
    2019.03 - 현재 연세대학교 의과대학 산부인과학교실 임상조교수

기타 학술 관련 경력

  • 대한부인종양학회 정회원
    제27차 대한산부인과내시경, 최소침습수술학회 최우수 구연상 (2017)
    연세대학교 의과대학 우수학술상 (2017)
    연세대학교 우수논문 장려상 (2017)
    서울시의사회 젊은의학자 논문상 (2018)
    부인종양 의학상: 젊은 의학자상 (2018)

연구,관심분야

  • 유전성 부인암, 부인과 내시경 수술, 부인암 중개연구

논문

  • <제1저자>
  • 1. Role of surgical therapy in the management of gestational trophoblastic neoplasia. Obstet Gynecol Sci. 2015;58:277-83.
  • 2. Malnutrition Identified by the Nutritional risk index and poor prognosis in advanced epithelial ovarian carcinoma. Nutr Cancer. 2016;68:772-9.
  • 3. The long noncoding RNA HOXA11 antisense induces tumor progression and stemness maintenance in cervical cancer. Oncotarget. 2016;7:83001-16.
  • 4. Role of systematic lymphadenectomy as part of primary debulking surgery for optimally cytoreduced advanced ovarian cancer: Reappraisal in the era of radical surgery. Oncotarget. 2017;8:37807-16.
  • 5. Comparison of clinical outcomes of BRCA1/2 pathologic mutation, variants of unknown significance, or wild type epithelial ovarian cancer patients. Cancer Res Treat. 2017;49:408-15.
  • 6. and BRCA2 mutation predictions using the BRCAPRO and Myriad models in Korean ovarian cancer patients. Gynecol Oncol. 2017;145:137-41.
  • 7. The efficacy of systematic lymph node dissection in advanced epithelial ovarian cancer during interval debulking surgery performed after neoadjuvant chemotherapy. J Surg Oncol. 2017; 116:329-336.
  • 8. A novel algorithm for the treatment strategy for advanced epithelial ovarian cancer: consecutive imaging, frailty assessment, and diagnostic laparoscopy. BMC Cancer. 2017;17:481.
  • 9. Upregulation of homeobox gene is correlated with poor survival outcomes in cervical cancer. Oncotarget. 2017;8:84396-84402.
  • 10. Dysregulated expression of homeobox family genes may influence survival outcomes of patients with epithelial ovarian cancer: analysis of data from The Cancer Genome Atlas. Oncotarget. 2017;8:70579-85.
  • 11. Long-term survival analysis of intraperitoneal versus intravenous chemotherapy for primary ovarian cancer and comparison between carboplatin- and cisplatin-based intraperitoneal chemotherapy. J Korean Med Sci. 2017 32;12:2021-2028.
  • 12. Long noncoding RNA steroid receptor activator induces tumor proliferation and invasion through the NOTCH pathway in cervical cancer cell lines. Oncol Rep. 2017 38(6):3481-3488
  • 13. Detection of germline mutations in patients with epithelial ovarian cancer using multi-gene panels: beyond BRCA 1/2. Cancer Res Treat. 2018 Jul;50(3):917-925. doi: 10.4143/crt.2017.220.
  • 14. Comparison of clinical features and outcomes in epithelial ovarian cancer according to tumorigenicity in patient-derived xenograft models. Cancer Res Treat. 2018 Jul;50(3):956-963. doi: 10.4143/crt.2017.181.
  • 15. MicroRNA-630 inhibitor sensitizes chemoresistant ovarian cancer to chemotherapy by enhancing apoptosis. Biochem Biophys Res Commun. 2018 Mar 4;497(2):513-520. doi: 10.1016/j.bbrc.2018.02.062.
  • 16. Periumbilical Infiltration of Lidocaine with Epinephrine for Postoperative Pain Reduction in Single-port Laparoscopic Adnexal Surgery. J Obstet Gynaecol. 2018 Sep 12:1-5. doi: 10.1080/01443615.2018.1455079.
  • 17. Two-step sentinel lymph node mapping strategy in endometrial cancer staging using fluorescent imaging: A novel sentinel lymph node tracer injection procedure. Surg Oncol. 2018 Sep;27(3):514-519. doi: 10.1016/j.suronc.2018.07.001.
  • 18. Distinct Clinical Courses of Epithelial Ovarian Cancer with Mutations in BRCA1 5’ and 3’ Exons. Anticancer Res. 2018 Dec;38(12):6947-6953. doi: 10.21873/anticanres.13073.
  •  
  • <공동저자>
  • 1. Surgical technique for single-port laparoscopy in huge ovarian tumors: SW Kim's technique and comparison to laparotomy. Obstet Gynecol Sci. 2017;60:178-86.
  • 2. A novel clinicopathological analysis of early stage ovarian Sertoli-Leydig cell tumors at a single institution. Obstet Gynecol Sci. 2017;60:39-45.
  • 3. Maternal serum placental growth factor and pregnancy-associated plasma protein A measured in the first trimester as parameters of subsequent pre-eclampsia and small-for-gestational-age infants: A prospective observational study. Obstet Gynecol Sci. 2017;60:154-62.
  • 4. Perioperative Outcomes of 3-Arm Versus 4-Arm Robotic Radical Hysterectomy in Patients with Cervical Cancer. J Minim Invasive Gynecol. 2017 Dec 26. pii: S1553-4650(17)31338-9.
  • 5. In-bag power morcellation technique in single-port laparoscopic myomectomy. Obstet Gynecol Sci. 2018 Mar;61(2):267-273.
  • 6. Survival impact of low anterior resection in patients with epithelial ovarian cancer grossly confined to the pelvic cavity: a Korean multicenter study. J Gynecol Oncol. 2018 Jul;29(4):e60. doi: 10.3802/jgo.2018.29.e60.
  • 7. Aberrant uterine leiomyomas with extrauterine manifestation: intravenous leiomyomatosis and benign metastasizing leiomyomas. Obstet Gynecol Sci. 2018 Jul;61(4):509-519. doi: 10.5468/ogs.2018.61.4.509.
  • 8. Expression levels of the long noncoding RNA steroid receptor activator promote cell proliferation and invasion and predict patient prognosis in human cervical cancer. Oncol Lett. 2018 Oct;16(4):5410-5418. doi: 10.3892/ol.2018.9265.
  • 9. The Combination of MEK inhibitor with Immunomodulatory Antibodies Targeting PD-1 and PD-L1 Results in Prolonged Survival in Kras/p53-Driven Lung Cancer. J Thorac Oncol. 2019 Feb 13. pii: S1556-0864(19)30111-X. doi: 10.1016/j.jtho.2019.02.004.
  • 10. Combined Aurora kinase A (AURKA) and WEE1 inhibition demonstrates synergistic antitumor effect in squamous cell carcinoma of the head and neck. Clin Cancer Res. 2019 Feb 12. pii: clincanres.0440.2018. doi: 10.1158/1078-0432.CCR-18-0440.
  • Distinct Clinical Courses of Epithelial Ovarian Cancer with Mutations in BRCA1 5’ and 3’ Exons
    ANTICANCER RESEARCH 38/12 :6,947-6,953,2018

어경진

콘텐츠 처음으로 이동

네크워크 링크안내/사이트 정보